drugset / Trial / NCT04152317

Dose Comparison of Misoprostol for Cervix Ripening Before Operative Hysteroscopy.

NCT04152317

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The medication misoprostol is used to facilitate the entry into the uterus of hysteroscopy surgery equipment and this research aims to compare the results of the use of this drug in two different doses trying to find the optimal one. To perform this work we will use the misoprostol and will perform a questionnaire that will be asked during hospitalization, before, during and the 12hours after the surgery. The patients who meet the inclusion criteria after signing the Informed Consent Form will be allocated into two groups getting misoprostol 200mcg or misoprostol 800mcg.

Timeline

Start
2019-11-07
Primary completion
2020-09-11
Completion
2020-09-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 200 ug Intravenous
Subject Misoprostol Other / unclassified 800 ug Intravenous

Indications